A custom mRNA vaccine is the first to succeed in a phase 3 trial. Learn how personalized cancer vaccines work and what to watch for at ESMO 2026.
|Videos|July 11, 2020
CURE Community Vlog: One Patient's Journey With Merkel Cell Carcinoma
Author(s)Kristie L. Kahl
“You have to speak up. What you don’t say is the most predictive of the care you don’t get.”
Advertisement
In just 10 days, Sue began her journey with Merkel cell carcinoma — a rare type of skin cancer that usually appears as a flesh-colored or bluish-red nodule, often on your face, head or neck.
She underwent seven surgeries on the left side of her nostril before receiving chemotherapy and radiation.
“There was so little research at the time,” she recalled.
“You have to speak up. What you don’t say is the most predictive of the care you don’t get.”
Newsletter
Stay up to date on cancer updates, research and education
SubscribeAdvertisement
Related to this article
In a video interview with CURE, Dr. Elizabeth K. Lee explained that how a treatment affects daily life matters as much as how well it works.
Dr. Neel Chudgar of Montefiore Einstein answers the most searched questions about lung cancer surgery, including risks, recovery and recurrence.
Rinatabart sesutecan shrank tumors in 45.9% of patients with platinum-resistant ovarian cancer in a phase 2 study, with responses lasting a median of 12.1 months.
Ameluz photodynamic therapy is the first light-based treatment the FDA has approved for a skin cancer. Here's who it's for, how it works and how it compares with surgery.
Advertisement
Advertisement